The Role of Oncolytic Viruses in the Treatment of Melanoma
/in International Publications, Malignant Melanoma, Newcastle Disease VirusFurther clinical advancement of dendritic cell vaccination against ovarian cancer
/in Dendritic Cells, International Publications, Ovarian CancerCombining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy
/in Checkpoint-Inhibitors, International PublicationsMolecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
/in Dendritic Cells, Glioblastoma, International PublicationsEnhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
/in Cervical Cancer, Hyperthermia, International PublicationsComparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials
/in Dendritic Cells, Glioblastoma, International PublicationsComplementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
/in Dendritic Cells, International Publications, Malignant MelanomaIntegrating oncolytic viruses in combination cancer immunotherapy
/in International Publications, Newcastle Disease VirusBiological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group
/in Brain Tumors in Children, International Publications, IOZK Veröffentlichungen
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer